CropamezoleTM is a dexmedetomidine and medetomidine reversing agent for use in dogs

Sedative and Analgesic Reversing Agent 5.0 mg/mL Sterile Injectable Solution

DOGS: Indicated for the reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride, and medetomidine hydrochloride.

CropamezoleTM is administered intramuscularly (IM) for reversal of sedation and analgesia regardless of the route used for dexmedetomidine hydrochloride or medetomidine hydrochloride.

For use in dogs older than four months of age and weighing more than 4.4 lbs (2 kg).

Each mL contains 5.0 mg atipamezole hydrochloride, 1.0 mg methylparaben (NF), 8.5 mg sodium chloride (USP), and water for injection (USP).

FDA approved under ANADA #200-753; this product is considered a generic equivalent to the reference product, Antisedan®.

Available in:

• 10 mL multi-dose, rubber-stoppered glass vials.

Cropamezole atipamezole hydrochloride

For more information about Cronus Pharma products please contact your authorized distributor.

1 (844) 227-6687

Cronus Pharma LLC is a fully integrated R&D, manufacturing, and marketing animal health pharmaceutical company located in East Brunswick, New Jersey. Dedicated to providing quality and cost-effective pharmaceuticals to the U.S. animal health market, our products are accessible to all veterinarians and pet owners through national and regional distributors.

Cronus Pharma © 2023 All Rights Reserved. Antisedan® is a trademark of Orion Corporation.

Please refer to Package Insert for full prescribing information, including safety information.

Cronus Pharma © 2023 All Rights Reserved